IOF World Congress on Osteoporosis

Back to Homepage

Satellite Symposia
(updated 26.4.2002)

Tuesday, May 14, 2002
17:45 – 19:45 (Auditorium 2)

Management of Pain With COX-2 Inhibition

Sponsor: Merck, Sharpe & Dohme

Chair: P.D. Delmas


P.D. Delmas

Advances in the treatment osteoarthritis: The gastrointestinal tolerability of COX-2 inhibition
A. Lanas-Spain

Safety profiles: Clinical effects of COX-1 and COX-2 inhibition
J. Pereira da Silva

New clinical studies with Rofecoxib: Latest clinical efficacy data in OA and RA and low back pain
M. Hochberg

Advances in acute/peri-operative pain management with Rofecoxib
R. Sinatra

Question and answer session

Closing remarks
P.D. Delmas